June 28, 2019 | City of Hope
At ASCO, City of Hope presented on a number of topics, but some of the most noteworthy involved the first KRAS inhibitor to show anti-tumor activity and the use of CAR T cell therapy in chronic lymphocytic leukemia.
City of hope's bone marrow transplant program reaches two historic milestones
February 26, 2019 | City of Hope
City of Hope’s bone marrow transplant has played a crucial role in the advancement of the procedure that it began doing more than four decades ago.
Researcher's Ovarian Cancer Discovery Takes on Special Meaning
June 27, 2018 | City of Hope
The results of a study published earlier this year by TGen researchers (City of Hope affiliate) in the journal Clinical Cancer Research suggest an existing leukemia drug, ponatinib, shows promise against SCCOHT.
City of Hope Guides ASCO’s New Geriatric Cancer Recommendations
June 8, 2018 | Saundra Young
City of Hope physicians Arti Hurria, M.D., a geriatric oncologist, and William Dale, M.D., Ph.D., a geriatrician and palliative care physician, co-chaired the panel that developed the new ASCO guidelines designed to help doctors assess and manage care for older adults.
City of Hope Researchers Publish First Report on a Protein Inhibitor for Advanced Bladder Cancer
June 8, 2018 | Letisia Marquez
Advanced bladder cancer is particularly difficult to treat. The five-year survival rate for Stage 4 bladder cancer is only about 15 percent. Now, City of Hope researchers have discovered a that a novel drug blocks a key protein that drives the disease.
City of Hope to offer CAR T cell therapy for patients with the most common type of NHL
May 4, 2018 | Letisia Marquez
City of Hope recently announced that it is one of the first treatment centers certified in the United States to administer tisagenlecleucel CAR T cell therapy to adult patients with relapsed or refractory large B cell lymphoma.
City of Hope to provide first FDA-approved CAR T cell therapy for some patients with ALL
April 13, 2018 | City of Hope
City of Hope recently announced that it is a certified treatment center to administer tisagenlecleucel CAR T cell therapy – the first CAR T cell therapy approved by the U.S. Food and Drug Administration – to patients.
City of Hope Expands Radiation Oncology Offering Across Southern California
April 2, 2018 | City of Hope
City of Hope today announced it is adding nine radiation oncology sites to City of Hope Medical Foundation through a joint venture with Vantage Oncology